Chanectin 1 % Solution for Injection for Cattle

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Cómpralo ahora

Ficha técnica Ficha técnica (SPC)
23-11-2018
DSU DSU (DSU)
23-06-2022

Ingredientes activos:

Ivermectin

Disponible desde:

Chanelle Pharmaceuticals Manufacturing Limited

Código ATC:

QP54AA01

Designación común internacional (DCI):

Ivermectin

Dosis:

1.0 percent weight/volume

formulario farmacéutico:

Solution for injection

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Área terapéutica:

ivermectin

Estado de Autorización:

Authorised

Fecha de autorización:

2001-06-20

Ficha técnica

                                Health Products Regulatory Authority
22 November 2018
CRN008PVZ
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Chanectin 1 % Solution for Injection for Cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance: Ivermectin 1.0% w/v
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for Injection.
A clear, colourless solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (Beef and non lactating cattle)
The veterinary medicinal product can be given to all ages of animals
including young
calves.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The veterinary medicinal product is indicated for the effective
treatment and control
of the following harmful parasites of cattle:
GASTRO-INTESTINAL ROUNDWORMS:
_Ostertagia_ spp (including inhibited _O. ostertagi (adult and L4)_),
_Haemonchus placei (adult and L4_),
_Trichostrongylus _spp._ (adult and L4_),
_Cooperia_ spp _(adult and L4_),
_Nematodirus _spp._ (adult_),
LUNGWORMS (adult and fourth stage larvae):
_Dictyocaulus viviparus_
WARBLES (parasitic stages):
_Hypoderma _spp.
MANGE MITES :
_Psoroptes bovis_
Health Products Regulatory Authority
22 November 2018
CRN008PVZ
Page 2 of 6
_Sarcoptes scabiei_ var. _bovis_.
SUCKING LICE :
_Linognathus vituli_,
_Haematopinus eurysternus_
PERSISTENT ACTIVITY
Treatment at the recommended dose rate controls re-infection with
_Haemonchusplacei_ and _Cooperia spp. _acquired up to 14 days after
treatment,
_Ostertagia ostertagi_ acquired up to 21 days after treatment and
_Dictyocaulus _
_viviparus_ acquired up to 28 days after treatment.
To obtain maximum benefit from the persistent activity of the
veterinary medicinal
product for grazing animals it is recommended that calves which are
set-stocked in
their first grazing season should be treated 3, 8 and 13 weeks after
the day of
turn-out. This can protect the animals from parasitic gastro-enteritis
and lungworm
disease throughout the grazing season, provided they are set-stocked,
all the calves
are inc
                                
                                Leer el documento completo
                                
                            

Buscar alertas relacionadas con este producto